19. March 2026 | Corporate News

Marinomed Biotech Announces Capital increase with subscription rights

  • Corporate action to meet short-term capital requirements
  • Corporate action supported by an institutional investor
  • Public shareholders have the opportunity to participate in the capital increase through subscription rights
  • Preliminary figures for 2025

The full press release is available as download here:

Marinomed Biotech Announces Capital increase with subscription rights
(186 KB)